STOCK TITAN
  1. Home
  2. Sec-filings
  3. GSK
  4. [6-K] GSK plc Current Report (Foreign Issuer)

GSK executive buys 9.8 ADS in savings plan

A GSK plc executive acquired a small number of notional ADS in a supplemental savings plan at $48.54 per ADS.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

GSK plc (GSK) reported a transaction by senior executive Maya Martinez-Davis, President, involving American Depositary Shares (ADS).

On September 8, 2026, Ms Martinez-Davis acquired 9.837 notional ADS within her GSK Executive Supplemental Savings Plan account at a price of $48.5400 per ADS on the New York Stock Exchange.

Positive

  • None.

Negative

  • None.
ADS price $48.5400 per ADS Price of notional ADS acquired on September 8, 2026
ADS volume acquired 9.837 ADS Notional ADS acquired within Executive Supplemental Savings Plan
Transaction date September 8, 2026 Date of ADS acquisition by Maya Martinez-Davis
American Depositary Shares financial
"Description of the financial instrument | American Depositary Shares (‘ADS’)"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
notional ADS financial
"Acquisition of notional ADS within Ms Martinez-Davis’s GSK Executive"
Executive Supplemental Savings Plan financial
"within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account"
LEI financial
"Name | GSK plc b) | LEI | 5493000HZTVUYLO1D793"
A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

FAQ

What was the price of the ADS acquired by the GSK (GSK) executive?
The notional American Depositary Shares acquired within the executive’s GSK Executive Supplemental Savings Plan account were priced at $48.5400 per ADS.

How many ADS were involved in the GSK (GSK) executive’s plan transaction?
The transaction involved the acquisition of 9.837 notional American Depositary Shares within Maya Martinez-Davis’s GSK Executive Supplemental Savings Plan account.

When did the GSK (GSK) executive ADS transaction take place?
The acquisition of 9.837 notional American Depositary Shares by Maya Martinez-Davis within her GSK Executive Supplemental Savings Plan account occurred on September 8, 2026.

On which exchange were the GSK (GSK) ADS associated with this transaction listed?
The American Depositary Shares related to this transaction are listed on the New York Stock Exchange (XNYS).

What type of security was involved in the GSK (GSK) executive transaction?
The transaction involved American Depositary Shares (ADS) of GSK plc, identified with ISIN US37733W2044.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of September 2026
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
79 New Oxford Street, London, WC1A 1DG
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
GSK plc (the ‘Company’)
 
Transaction notification
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
 
a)
Name
Maya Martinez-Davis
 
b)
Position/status
President, US
 
c)
Initial notification/amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares (‘ADS’)
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Acquisition of notional ADS within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account
 
c)
Price(s) and
volume(s)
 
Price(s)
Volume(s)
 
 
 
$48.5400
9.837
 
 
 
 
 
 
d)
Aggregated information
 
 
N/A (single transaction)
Aggregated volume
 
Price
 
 
e)
Date of the transaction
2026-09-08
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:
No. 3888792
 
Registered Office:
79 New Oxford Street
London
WC1A 1DG
  
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: September 10, 2026
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc
 

Source: View Original Filing on SEC EDGAR

Keep reading

More on GSK

Trending in the feed

Open the live feed